197915-37-0

Basic information

• Product Name: 2-[2-(4-aminophenyl)ethyl]-5-[2-tert-butyl-4-(hydroxymethyl)-5-methyl-phenyl]sulfanyl-6-hydroxy-2-phenyl-3H-pyran-4-one
• Synonyms: 2-[2-(4-aminophenyl)ethyl]-5-{[2-tert-butyl-4-(hydroxymethyl)-5-methylphenyl]sulfanyl}-6-hydroxy-2-phenyl-2,3-dihydro-4H-pyran-4-one; 4H-pyran-4-one, 2-[2-(4-aminophenyl)ethyl]-5-[[2-(1,1-dimethylethyl)-4-(hydroxymethyl)-5-methylphenyl]thio]-2,3-dihydro-6-hydroxy-2-phenyl-
• CAS NO: 197915-37-0
• Molecular Formula: C₃₁H₃₅NO₄S
• Molecular Weight: 517.6789
• Mol File: 197915-37-0.mol

Chemical Properties

• Boiling Point: 660.4°C at 760 mmHg
• Flash Point: 353.2°C
• Density: 1.26g/cm³
• Vapor Pressure: 2.44E-18mmHg at 25°C
• Refractive Index: 1.656
• CAS DataBase Reference: 2-[2-(4-aminophenyl)ethyl]-5-[2-tert-butyl-4-(hydroxymethyl)-5-methyl-phenyl]sulfanyl-6-hydroxy-2-phenyl-3H-pyran-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-(4-aminophenyl)ethyl]-5-[2-tert-butyl-4-(hydroxymethyl)-5-methyl-phenyl]sulfanyl-6-hydroxy-2-phenyl-3H-pyran-4-one(197915-37-0)
• EPA Substance Registry System: 2-[2-(4-aminophenyl)ethyl]-5-[2-tert-butyl-4-(hydroxymethyl)-5-methyl-phenyl]sulfanyl-6-hydroxy-2-phenyl-3H-pyran-4-one(197915-37-0)

Safety Data

• Hazardous Substances Data: 197915-37-0(Hazardous Substances Data)

Usage

Pyranone ring

A six-membered oxygen-containing ring structure that is part of the compound's core structure.

Sulfhydryl group (-SH)

A functional group consisting of a sulfur atom bonded to a hydrogen atom, which is connected to a phenyl ring in this compound.

Phenyl ring

A six-membered carbon ring with alternating single and double bonds, which is a part of the sulfhydryl group's structure.

Tert-butyl group (-C(CH3)3)

A bulky, three-carbon alkyl group with three methyl groups attached to the central carbon atom, which acts as a substituent in this compound.

Hydroxymethyl group (-CH2OH)

A functional group consisting of a methylene group (-CH2-) bonded to a hydroxyl group (-OH), which is another substituent in the compound.

Amine group (-NH2)

A functional group consisting of a nitrogen atom bonded to two hydrogen atoms, which is present in the 4-aminophenyl moiety of the compound.

Hydroxyl group (-OH)

A functional group consisting of an oxygen atom bonded to a hydrogen atom, which is part of the hydroxymethyl group.

Potential reactivity in biological systems

The presence of amine and hydroxyl groups may make the compound reactive with other molecules in biological systems, such as proteins or enzymes.

Pharmacological or biological activity

The arrangement of various functional groups in the compound suggests that it may have some pharmacological or biological activity, although further research is needed to determine its specific properties and potential applications.

Upstream product

• 207737-06-2 toluene-4-thiosulfonic acid S-(2-tert-butyl-4-hydroxymethyl-5-methyl-phenyl) ester 
• 62056-28-4 N-(4-(3-oxo-3-phenylpropyl)phenyl)acetamide 
• 51345-97-2 4-Bromo-2-tert-butyl-5-methyl-phenol 
• 207737-05-1 2-tert-Butyl-4-hydroxymethyl-5-methylthiophenol 
• 584-08-7 potassium carbonate 
• 207736-93-4 6-[2-(4-acetylaminophenyl)ethyl]-4-hydroxy-6-phenyl-5,6-dihydropyran-2-one 
• 207737-01-7 5-tert-Butyl-4-(2-methoxy-ethoxymethoxy)-2-methyl-benzoic acid 
• 207737-03-9 5-tert-Butyl-4-dimethylthiocarbamoyloxy-2-methyl-benzoic acid methyl ester 
• 207737-04-0 5-tert-Butyl-4-dimethylcarbamoylsulfanyl-2-methyl-benzoic acid methyl ester 
• 207737-02-8 5-tert-Butyl-4-hydroxy-2-methyl-benzoic acid methyl ester 
• 59276-79-8 3-(4-aminophenyl)-1-phenylpropan-1-one 
• 88-60-8 2-tert-Butyl-5-methylphenol 
• 207737-00-6 1-Bromo-5-tert-butyl-4-(2-methoxy-ethoxymethoxy)-2-methyl-benzene 

Relevant articles and documents

Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: A lead HIV protease inhibitor

With the insight generated by the availability of X-ray crystal structures of various 5,6-dihydropyran-2-ones bound to HIV PR, inhibitors possessing various alkyl groups at the 6-position of 5,6-dihydropyran-2-one ring were synthesized. The inhibitors pos

Dihydropyrones with improved antiviral activity

This invention pertains to improved antiviral activity of 6,6-disubstituted-5,6-dihydropyran-2-ones caused by judicious placement of certain polar substituents at the 3 and/or 6 positions. The same substituents which enhance the cellular activity also